Nymox Pharmaceutical Corporation

(NYMX) Trade

By |

Profile

Nymox Pharmaceutical Corp, along with its subsidiaries, is a biopharmaceutical corporation, engaged in research and development of drugs and diagnostic products for aging population. Its product portfolio consists of Nic alert and Tobac alert.

Contact Information

Website: www.nymox.com
Email: uex@uex-corporation.com
Main Phone: +1242 8009369669
Address: Bay & Deveaux Streets
Address 2: Unit 200
State: SK
City / Town: Nassau
Country: BHS
Postal Code: S7P 0B6

Issuer Information

Exchange: NSC
CEO: Paul Averback
Employees: 2
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 2.67 $ -0.02 (-0.74%)
Last Price 2.67 Change $ -0.02 Change % -0.74 Tick N/A
Bid 2.50 Bid Size 10,000.00 Ask 3.00 Ask Size 3,000.00
Open 2.68 High 2.69 Low 2.65 Prev Close 2.69
Last Trade Volume 132,348 52 Wk Hi 4.60 52 Wk Low 2.46
Market Cap 162.2 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 60,743,000.00 EPS (TTM) -0.24 PE Ratio N/A Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 4 74
Number of Buys 4 74
Number of Sells 0 0
Net Activity 16000 129500
Last 10 Buys Shares
James G. Robinson 1,000
James G. Robinson 1,000
James G. Robinson 1,000
James G. Robinson 1,000
James G. Robinson 1,000
James G. Robinson 1,000
James G. Robinson 1,000
James G. Robinson 1,000
James G. Robinson 1,000
James G. Robinson 1,000
Last 10 Sell Shares
N/A 0
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 9.5 9.5 9.5 9.5
Low Target Price Estimate 9.5 9.5 9.5 9.5
Mean Target Price Estimate 9.5 9.5 9.5 9.5
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 03/06/13 03/06/13 03/06/13 03/06/13
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 0 0 0 1